Fundz

Fundz Deep Dive

Everything you need to win Dr Agnès Arbat — in one platform.

Who to reach, what to say, and why now on Dr Agnès Arbat — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Dr Agnès Arbat — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Oriva Therapeutics Appoints Dr Agnès Arbat As Chief Executive Officer and Chief Medical Officer

PRIVATEJun 11, 20265 days ago

Position

Chief Medical Officer

Company

Oriva Therapeutics

Dr Agnès Arbat
BiotechnologyHealth CareTherapeutics

Description

Dr Agnès Arbat has been appointed as the Chief Executive Officer and Chief Medical Officer at Oriva Therapeutics. With over 25 years of experience in the pharmaceutical industry, Dr Arbat is well-equipped to lead the company during its growth phase.

Company Information

Company

Oriva Therapeutics

About

Oriva Therapeutics is a biotech company focused on advancing innovative treatments for women's health. The company was founded with the support of Asabys Partners and is developing a clinical-stage pipeline that addresses significant unmet medical needs. Oriva aims to provide best-in-class treatments for common gynaecological conditions, leveraging novel chemistry in their drug development.

Predictive Intelligence
Strategic

ML-powered predictions for Oriva Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.